Glutamate release studies on alpha 2/delta compounds in vitro using glutamate sensitive electrodes

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/07 → 9/30/09

Funding

  • Pfizer Inc.: $187,520.00